Topical Pain Options Compared: Lidocaine, Diclofenac, Capsaicin & More

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 29, 2026 | 10 min read

Topical analgesics including lidocaine patches, diclofenac gel, capsaicin cream, and compounded topical preparations each target different pain mechanisms through local application, minimizing systemic side effects while providing localized relief for injury-specific pain. The choice of topical agent documents both the type and location of pain, creating targeted evidence of the injury's ongoing impact.

Topical analgesics are locally applied pain medications that target specific injury sites without the systemic side effects of oral medications. Lidocaine patches, diclofenac gel, capsaicin cream, and compounded topical preparations each address different pain mechanisms, and the prescriber's selection of a specific topical agent documents the type, location, and chronicity of the patient's injury-related pain.

• Lidocaine patches and creams block sodium channels at the injury site, treating localized neuropathic and musculoskeletal pain
• Diclofenac gel provides topical NSAID anti-inflammatory action directly at the pain source without GI risks of oral NSAIDs
• Capsaicin cream depletes substance P from peripheral nerve endings, treating chronic neuropathic pain
• Compounded topical preparations combine multiple mechanisms for complex pain not controlled by single agents
• LienScripts covers all topical analgesics under a pharmacy lien at zero upfront cost throughout the case

Lidocaine: Local Anesthetic for Neuropathic and Musculoskeletal Pain

Mechanism

Lidocaine blocks voltage-gated sodium channels in peripheral sensory nerves, preventing pain signal transmission from the injury site. This targeted mechanism provides pain relief at the application site without affecting the central nervous system.

Available Formulations

Lidocaine 5% Patch (Lidoderm): Applied directly over the painful area for up to 12 hours per day. Commonly prescribed for:

• Post-surgical incision pain
• Localized neuropathic pain from nerve damage
• Rib fracture pain
• Chronic low back pain at specific dermatomal levels

Lidocaine 4% Cream/Ointment: Applied 3-4 times daily for breakthrough pain. More flexible application than patches for irregular body contours.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains: "The lidocaine patch prescription tells the demand reviewer exactly where the patient hurts. Unlike oral medications that treat pain systemically, a prescription for lidocaine patches applied to the left lower back or the right shoulder directly maps the pain to the injury site documented in the medical record."

[!KEY] Topical analgesic prescriptions are uniquely valuable because they localize the pain. The application site documented on the prescription directly connects the medication to a specific injury, creating a medication-to-injury link that oral medications cannot provide.

Diclofenac: Topical NSAID Anti-Inflammatory

Mechanism

Diclofenac gel delivers a non-steroidal anti-inflammatory drug directly to inflamed tissue, inhibiting cyclooxygenase (COX) enzymes at the injury site. Topical application achieves therapeutic concentrations locally while maintaining minimal systemic absorption.

Available Formulations

Diclofenac 1% Gel (Voltaren): FDA-approved for osteoarthritis of joints amenable to topical treatment. Applied 4 times daily.

Diclofenac 1.5% Solution: Used for larger joint areas. Applied 3 times daily.

Diclofenac Patch (Flector): Provides sustained delivery for localized acute pain.

PI Case Application

Diclofenac gel is frequently prescribed when oral NSAIDs cause gastrointestinal side effects or when the patient is on anticoagulants. The switch from oral to topical NSAID documents:

• Ongoing inflammation at the injury site requiring anti-inflammatory treatment
• GI complications from oral medications, adding a treatment complexity layer
• Localized nature of the inflammatory pain

[!TIP] If a patient transitions from oral ibuprofen or naproxen to topical diclofenac, present this as evidence that the pain persisted beyond the acute phase and required a more targeted treatment approach. The topical formulation documents that the injury site remains inflamed months after the accident.

Capsaicin: Chronic Neuropathic Pain Evidence

Mechanism

Capsaicin activates and then depletes TRPV1 receptors on C-fiber nociceptors, reducing the concentration of substance P (a pain neurotransmitter) in peripheral nerve endings. This mechanism requires regular application over 2-4 weeks before full analgesic effect, demonstrating commitment to chronic pain management.

Available Formulations

Capsaicin 0.025-0.075% Cream: Applied 3-4 times daily. Initial burning sensation is expected and diminishes with continued use.

Capsaicin 8% Patch (Qutenza): High-concentration prescription patch applied in-office for 30-60 minutes, providing up to 3 months of pain relief per application. Indicated for neuropathic pain.

Documentation Value

Capsaicin prescription documents:

• Neuropathic pain component: Capsaicin specifically targets neuropathic pain, distinguishing it from simple musculoskeletal soreness
• Chronicity: The 2-4 week onset period means capsaicin is only prescribed for pain expected to persist
• Treatment escalation: Addition of capsaicin after other topicals have been tried documents progressive treatment complexity

Compounded Topical Preparations

What They Are

Compounded topical preparations combine multiple active ingredients into a single cream or gel customized for the patient's specific pain profile. Common ingredients include:

• Ketamine (NMDA receptor antagonist) for neuropathic pain
• Gabapentin (topical form) for localized nerve pain
• Baclofen (muscle relaxant) for localized muscle spasm
• Cyclobenzaprine (topical form) for myofascial pain
• Diclofenac (NSAID) for inflammation
• Lidocaine (local anesthetic) for immediate pain relief

PI Case Significance

Compounded preparations document treatment complexity at the highest level:

1. Customization: The patient's pain is complex enough that no single commercial product is adequate
2. Multiple mechanisms: Each ingredient targets a different pain pathway
3. Prescriber expertise: Compounded prescriptions typically come from pain management specialists
4. Cost documentation: Compounded preparations are generally more expensive than commercial products, supporting the damages claim

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages that explains each topical agent's mechanism and its clinical rationale for the patient's specific injury.

When Each Topical Agent Is Appropriate

Topical-to-Systemic Escalation

When topical agents fail to provide adequate relief and the patient transitions to systemic (oral or injectable) pain medications, the escalation documents treatment failure and increasing pain severity. The topical trial period demonstrates that conservative, localized treatment was attempted first, strengthening the argument that subsequent systemic medications were medically necessary.

Pharmacy Lien Coverage

LienScripts covers all topical analgesics -- from lidocaine patches and diclofenac gel through custom compounded preparations -- under a pharmacy lien at zero upfront cost. The LienScripts platform ensures patients receive the specific topical agent their prescriber selects without formulary restrictions or prior authorization delays.

Related Resources

• Topical vs. Oral NSAIDs in Personal Injury
• Topical Compound Cream Pharmacy Lien Justification
• Topical Pain Medication Guide for PI